Table 3.
Clinicopathological features of patients with IgAN at time of biopsy.
| Variable | Value |
|---|---|
| Age (years) | 33 (27–42) |
| Male (%) | 43.98 |
| Ethnicity (% Asian) | 100 |
| BMI (kg/m2) | 23.0 ± 3.7 |
| SBP (mm Hg) | 126.9 ± 14.8 |
| DBP (mm Hg) | 78.2 ± 11.3 |
| MAP (mm Hg) | 94.2 ± 12.5 |
| Hypertension before biopsy (%) | 20.2 |
| Serum creatinine (mg/dl) | 0.96 (0.76–1.34) |
| eGFR (ml/min per 1.72m2) | 78.2 (57.5–107.0) |
| CKD stage (%) | |
| 1 | 50 |
| 2 | 28.3 |
| 3 | 17.3 |
| 4 | 3.5 |
| 5 | 0.9 |
| Proteinuria (g/day) | 1.1 (0.6–2.0) |
| Serum albumin (g/l) | 40.1 (36.6–43.0) |
| Serum cholesterol (mmol/l) | 4.6 (4.0–5.4) |
| Serum triglycerides (mmol/l) | 1.4 (1.0–2.0) |
| Serum uric acid (μmol/l) | 359 (303–428) |
| Oxford Classification (%) | |
| Ml | 29.9 |
| E1 | 22.5 |
| S1 | 86.1 |
| T1/T2 | 17.2/2.7 |
| C1/C2 | 87.3/3.0 |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; eGFR, estimated glomerular filtration rate (CKD‐EPI); CKD, chronic kidney disease; M, mesangial hypercellularity; E, endocapillary hypercellularity; S, segmental glomerular sclerosis; T, interstitial fibrosis and tubular atrophy; C, crescent.
Data are presented as the mean ± SD, the median with range or percentages.